To classify as strongly and widely as possible, or not to – that is the EU’s question on titanium dioxide right now. The chemical is found in many everyday items including sunscreen and paint and is a “suspected carcinogen”. Discussion of the classification issue are underway, and what is already clear is that the controversy about corporate lobbying on this file is making some member states think again.
Industry lobbyists are spending millions of euros to influence an upcoming EU decision on labelling titanium dioxide – found in everyday products like sunscreen – a “suspected carcinogen”. The lobbying is led by an unregistered trade association and a public relations consultancy; nonetheless, they appear to have the ear of member states and the European Commission.
Documents released to Corporate Europe Observatory following a Freedom of Information request reveal how pro-biotech lobby platform Public Research Regulation Initiative (PRRI) unites industry, researchers and regulators in ‘like-minded’ groups to influence crucial international biosafety talks under the UN Convention on Biological Diversity (CBD).